SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001355250-10-000029
Filing Date
2010-11-09
Accepted
2010-11-09 12:43:39
Documents
4
Period of Report
2010-11-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k.htm 8-K 24254
2 exh_99-1.htm EX-99.1 9768
3 exh_99-2.htm EX-99.2 3837
4 exh_99-3.htm EX-99.3 23973
  Complete submission text file 0001355250-10-000029.txt   63569
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-52321 | Film No.: 101175295
SIC: 2834 Pharmaceutical Preparations